DADA selectively and effectively inhibited PDK4, resulting in significant restoration of PDH activity as well as various metabolic disorders, such as ATP levels in various organs, and improved glucose, lactate and β-hydroxybutyric acid levels in the blood. Here, PDP1 is linked to Other metabolic disease.